Key result
Thrombocytopenia or inhibition of platelet aggregation resulted in about 35-50% reduction of retinal neovascularization in a mouse model of hypoxia-induced angiogenesis.
Blood platelets play a significant proangiogenic role in neovascularization, suggesting that anti-platelet substances may act as potent inhibitors of angiogenesis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for antiplatelet inhibition in retinal angiogenesis; leaves open translation to human disease.
The process of neovascularization greatly depends on the induction of the angiogenic phenotype of endothelial cells that is strictly controlled by humoral factors as well as by cellular communications in the vascular system. Although blood platelets contain several secretable pro- and antiangiogenic components, their overall role in angiogenesis remains poorly understood. In a mouse model of hypoxia-induced retinal angiogenesis, the situation of thrombocytopenia as well as inhibition of platelet aggregation by a highly specific alphaIIbbeta3-integrin antagonist or acetyl salicylic acid (Aspirin) administration, respectively, resulted in about 35-50% reduction of retinal neovascularization, compatible with a significant contribution of blood platelets in angiogenesis. Platelet remnants and microvesicles were found at sites of angiogenic sprouts. In vitro isolated platelets incorporated in a fibrin gel induced capillary sprouting of microvascular endothelial cells. Similarly, platelet releasate elevated the permeability of confluent endothelial cell monolayers to the same extent as hypoxia did. Platelet-derived VEGF as well as butanol-extractable lipid mediators were identified as predominant activators of angiogenesis, particularly of microvascular endothelial cell proliferation and migration. In addition, a synergistic effect between platelet-derived VEGF and bFGF in capillary sprouting and endothelial cell proliferation was found. Based on this proangiogenic role of platelets in neovascularization, anti-platelet substances can be considered as potent inhibitors of angiogenesis.
No takes yet. Share an insight, caveat, or question.
Fischer et al. (2004) studied Hypoxia-induced retinal angiogenesis. Thrombocytopenia or platelet aggregation inhibitors (alphaIIbbeta3-integrin antagonist, Aspirin) was evaluated on Retinal neovascularization. Thrombocytopenia or inhibition of platelet aggregation resulted in about 35-50% reduction of retinal neovascularization in a mouse model of hypoxia-induced angiogenesis.
Synapse has enriched 10 related papers. Consider them for comparative context: